PTEN and myeloid leukemia: Moreover, KIN193-treated animals appeared healthy and had significantly reduced spleen weights and normal-looking spleen architecture compared with vehicle-treated mice (Fig. 5d; Supplementary Fig. 8), consistent with our genetic data that ablation of p110β largely prevented myeloid leukaemia in Pten-deficient mice.